Some laboratories, including ours, have recently demonstrated the importance of E2F1 in the physiopathological context of non-alcoholic fatty liver disease (NAFLD), which is highly related to the epidemic of obesity. The gene discussed is E2F1; the disease is metabolic dysfunction-associated steatotic liver disease.